We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Tradipitant

News List

Tradipitant may accelerate recovery from COVID-19 pneumonia, finds interim analysis europeanpharmaceuticalreview
August 20, 2020
A preliminary analysis of data from the first COVID-19 pneumonia patients enrolled in the ODYSSEY trial revealed that tradipitant may expedite clinical improvement.
Vanda Initiates Study of Tradipitant in Hospitalized Patients with Severe COVID-19 Pneumonia americanpharmaceuticalreview
April 08, 2020
Vanda Pharmaceuticals announced the initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19.
Vanda Announces Positive Phase II Study Results for Tradipitant americanpharmaceuticalreview
December 04, 2018
Vanda Pharmaceuticals announced tradipitant met the primary endpoint in VLY686-2301, a Phase II clinical study in patients with idiopathic and diabetic gastroparesis......